Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
adenosine deaminase domain containing 1 | 0.821 | 0.269 | 3.9E-02 |
|
disease | 0.110 | None | 0.500 | 1 | 1 | 2009 | 2011 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.140 | None | 0.600 | 1 | 1 | 2005 | 2012 | ||||||||
|
transmembrane protein 39A | 0.839 | 0.231 | 0.95 |
|
disease | 0.120 | None | 0.667 | 1 | 1 | 2010 | 2012 | ||||||||
|
Pvt1 oncogene | 0.495 | 0.731 |
|
disease | 0.110 | None | 0.667 | 1 | 2 | 2011 | 2017 | |||||||||
|
SP140 nuclear body protein | 0.691 | 0.577 | 5.0E-08 |
|
disease | 0.120 | None | 0.750 | 1 | 1 | 2011 | 2018 | ||||||||
|
Cbl proto-oncogene B | 0.691 | 0.423 | 1.00 |
|
disease | 0.440 | None | 0.800 | 1 | 1 | 2010 | 2017 | ||||||||
|
transporter 2, ATP binding cassette subfamily B member | 0.517 | 0.808 | 6.9E-11 |
|
disease | 0.150 | None | 0.833 | 1 | 1 | 1994 | 2007 | ||||||||
|
major histocompatibility complex, class II, DQ alpha 1 | 0.416 | 0.846 | 2.4E-02 |
|
disease | 0.200 | None | 0.884 | 2 | 2 | 1991 | 2019 | ||||||||
|
interleukin 23 receptor | 0.466 | 0.769 | 5.6E-04 |
|
disease | 0.180 | None | 0.889 | 1 | 2 | 2007 | 2017 | ||||||||
|
cytochrome P450 family 27 subfamily B member 1 | 0.502 | 0.769 | 1.9E-07 |
|
disease | 0.200 | None | 0.905 | 1 | 1 | 2008 | 2019 | ||||||||
|
major histocompatibility complex, class I, A | 0.370 | 0.846 | 1.3E-03 |
|
disease | 0.200 | None | 0.919 | 1 | 1 | 1978 | 2019 | ||||||||
|
major histocompatibility complex, class II, DR beta 1 | 0.333 | 0.923 | 1.1E-03 |
|
disease | 0.500 | None | 0.923 | 1 | 2 | 1992 | 2020 | ||||||||
|
CD40 molecule | 0.396 | 0.846 | 0.85 |
|
disease | 0.500 | None | 0.958 | 1 | 1 | 2000 | 2019 | ||||||||
|
TNF receptor superfamily member 1A | 0.409 | 0.923 | 0.99 |
|
disease | 0.500 | None | 0.970 | 2 | 2 | 1999 | 2019 | ||||||||
|
interleukin 7 receptor | 0.487 | 0.769 | 3.8E-07 |
|
disease | 0.500 | None | 0.982 | 2 | 1 | 2003 | 2019 | ||||||||
|
interleukin 2 receptor subunit alpha | 0.389 | 0.885 | 5.5E-02 |
|
disease | 0.500 | None | 0.985 | 4 | 4 | 1994 | 2019 | ||||||||
|
CD58 molecule | 0.584 | 0.769 | 0.25 |
|
disease | 0.500 | None | 1.000 | 5 | 2 | 2008 | 2019 | ||||||||
|
TSBP1 and BTNL2 antisense RNA 1 | 0.638 | 0.692 |
|
disease | 0.100 | None | 1.000 | 5 | 27 | 2007 | 2013 | |||||||||
|
testis expressed basic protein 1 | 0.638 | 0.692 | 1.5E-16 |
|
disease | 0.100 | None | 1.000 | 4 | 17 | 2007 | 2012 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.200 | None | 1.000 | 3 | 3 | 2004 | 2020 | ||||||||
|
ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 | 0.729 | 0.385 | 1.00 |
|
disease | 0.100 | None | 1.000 | 2 | 1 | 2009 | 2011 | ||||||||
|
major histocompatibility complex, class I, B | 0.379 | 0.885 | 3.9E-05 |
|
disease | 0.200 | None | 1.000 | 2 | 5 | 1979 | 2019 | ||||||||
|
T cell activation RhoGTPase activating protein | 0.700 | 0.462 | 0.85 |
|
disease | 0.130 | None | 1.000 | 2 | 1 | 2011 | 2017 | ||||||||
|
tenascin XB | 0.572 | 0.731 | 1.9E-02 |
|
disease | 0.100 | None | 1.000 | 2 | 3 | 2007 | 2010 | ||||||||
|
BTB domain and CNC homolog 2 | 0.539 | 0.731 | 1.00 |
|
disease | 0.110 | None | 1.000 | 2 | 3 | 2011 | 2013 |